Blood test to find and monitor heart masses
Part of Heart & circulation clinical trials.
This trial uses a blood test (liquid biopsy) to help find and monitor heart masses without surgery. It may help diagnose what the mass is and how it changes over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 years old or older
- You have a heart mass that may be cancer or another type, based on standard tests
- You understand and can sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses cardiac MRI to better understand heart masses (tumors or clots) and guide treatment decisions. It may help determine what the mass is and how it affects your health.
This trial uses a special device to take a small blood sample from your heart arteries during a planned procedure. It aims to find unique markers that could help doctors better understand and treat coronary artery disease.
This study checks how special lab tests on heart tissue samples can help guide diagnosis and treatment for people with a heart transplant. You may be eligible if you already need a heart tissue biopsy for a clinical reason and can provide consent.
This trial uses a simple blood test to look at certain genetic markers that may help doctors decide if a lung nodule is cancerous or not. It is designed for people who have a lung nodule that needs further testing like a biopsy or surgery.
This study looks at people with different types of heart tumors to better understand their risks and outcomes. It aims to improve how doctors predict and manage future health events.
This study uses a simple blood test to look at the genetic makeup of your tumor. The results may help your doctors choose the best treatment for you. You will need to provide a tumor sample or have a biopsy.
Hear when a new Cardiac Masses trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.